by adminAdrianRamirez | Mar 1, 2017 | Axim Biotechnologies, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Press Releases
SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol...
by adminAdrianRamirez | Feb 14, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage
Medical Marijuana, Inc. VP of Operations Blake Schroeder and Andrew Hard, CEO of CMW Media, sat down with Drew Schlosberg of the San Diego Union-Tribune Community Spotlight late last week to discuss the cannabis industry and Medical Marijuana, Inc.’s role as a proven...
by adminAdrianRamirez | Jan 31, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Jan. 31, 2017 — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds® Mexico upon the one-year anniversary of the first-ever import...
by adminAdrianRamirez | Jan 30, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Jan. 30, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico has launched its new website, featuring a fresh interface,...
by adminAdrianRamirez | Jan 24, 2017 | HempMeds Mexico, Press Releases
Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being SAN DIEGO, Jan. 24, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received...